Sanctuary Advisors LLC Has $279,000 Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Sanctuary Advisors LLC trimmed its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 59.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,747 shares of the company’s stock after selling 16,918 shares during the quarter. Sanctuary Advisors LLC’s holdings in Phibro Animal Health were worth $279,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Sofinnova Investments Inc. bought a new position in shares of Phibro Animal Health during the second quarter worth approximately $3,975,000. Acadian Asset Management LLC increased its position in Phibro Animal Health by 6.3% during the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock worth $12,027,000 after buying an additional 42,299 shares during the period. Barclays PLC lifted its holdings in shares of Phibro Animal Health by 25.7% during the third quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after buying an additional 29,271 shares in the last quarter. Algert Global LLC grew its stake in shares of Phibro Animal Health by 521.1% in the third quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after acquiring an additional 59,850 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its position in Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after acquiring an additional 729 shares during the period. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $21.05 on Friday. The firm’s 50 day simple moving average is $23.29 and its 200 day simple moving average is $20.87. The firm has a market capitalization of $852.59 million, a price-to-earnings ratio of 48.95, a P/E/G ratio of 0.58 and a beta of 0.51. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. Phibro Animal Health Co. has a 1 year low of $10.03 and a 1 year high of $25.98.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is presently 111.63%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on PAHC. StockNews.com downgraded shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Friday. Morgan Stanley boosted their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Barclays raised their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. Finally, JPMorgan Chase & Co. began coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Phibro Animal Health has an average rating of “Hold” and an average target price of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.